A first-generation semi-automatic amperometric lactate anaIyzer (Yellow Springs Instrument Co.) was assessed for urgent ("stat"), rapid laboratory measurements in whole blood and cerebrospinal fluid. For whole blood, measured lactate concentration and hematocnt were linearly correlated. An improved equation is presented for estimating the concentration of lactate in plasma from measurements in whole blood. The 95% reference range for the concentration of lactate in paired samples of capillary and venous whole blood from 40 healthy laboratory adults was found to be 0.4-1.5 mmol/L and 0.3-1.5 mmol/L, respectively. The 95% ranges for lactate in whole blood from 24 uncomplicated vaginal deliveries at term were established for cord venous blood, 1.2-5.0 mmol/L; cord arterial blood, 1.6-5.5 mmol/L; and maternal venous blood, 1.7-6.6 mmol/L. The 95% paired ranges were established for 20 Iumbar-anaesthetized urological patients without neurological disorders after induction of anaesthesia for venous whole blood and cerebrospinal fluid (venous blood, 0.5-1.3 mmol/L; cerebrospinal fluid, 1.1-2.4 mmol/L). In recent years interest has been renewed in the diagnostic utility of an increased value for lactate in various sorts of critically ill patients (1), but because of instrumental limitations to simple stat measurements in whole blood, routine use in intensive care seems to have been confined to a few research laboratories. The recent development of a stat instrument (LA 640; Roche Bio-electronics, Basel) for measuring lactate in small volumes (100 L) of whole blood has provided laboratories with a facility (2-4) that may satisfy routine needs in the care of neonates (5-7) and medical patients (8) with acute cardiorespiratory failure. We assessed the stat function of an improved amperometric instrument (Stat Lactate Analyzer; Yellow Springs Instrument Co., Yellow Springs, OH) capableof measuring values for whole blood (25 iL), plasma, and cerebrospinal fluid (9). We examined the practicability of the instrument for measuring lactate in whole blood in the management of acute medical and obstetric sick patients. 
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Materials and Methods

Apparatus.
The analyzer measures lactate in a 25-jzL sample of whole blood, plasma, or cerebrospinal fluid.
The measuring chamber consists of a lactate-sensitive electrode and a thermistor to control the temperature (37 #{176}C). The reaction cell contains 350 L (YSI no. 2326), which means that there is a 14-fold dilution of the 25-FL sample with buffer when the sample is injected into the chamber.
The tip ofthe electrode consists ofthree layers. The outer layer is a polycarbonate membrane, which passes lactate, FAD, oxygen, hydrogen peroxide, water, and salts, but restricts the diffusion of enzymes and proteins. The inner layer is a cellulose acetate membrane, which excludes ascorbic acid and other interfering substances. Between the outer and inner layers, the sensor, iAactate oxidase (EC 1.1.1.27), is fixed by glutaraldehyde cross-linkage. The function of this amperometric sensor is described by the following reaction schemes: The erythrocyte effect. To assessthe effect of erythrocytes on the measurements and conversion of L-lactate in whole blood to values for plasma, we took a single sample from one of us (J.W.), separated the erythrocytes, and artificially obtained several samples with different hematocrits. The original sample was supplemented with lactate to increase the analytical precision. Metabolic events were controlled by separating the plasma from the cells and measuring L-lactate both in the plasma and in the artificial specimens of whole blood.
Storage of blood. Samples of whole blood were collected in containers with heparmnand potassium fluoride, and stored at temperatures of 0-4 #{176}C and 21-22 #{176}C and 37-38 #{176}C. Thereafter, the lactate concentration was regularly measured during 4 to 5 h, to assessthe mean change per hour in relation to storage of samples under above conditions.
Precision. The analytical standard deviation for lactate in whole blood and venous plasma was estimated from multiple measurements in tubes supplemented with lactate. The day-to-day analytical coefficient of variation (CV, %) for lactate was determined from each day's measurements of a control sample from a serum pool (4.1% at a concentration of 1.9 mmollL).
Clinical material. Reference values for venous and capillazy whole blood were obtained by use of blood from healthy adults. Maternal and cord blood were taken from uncomplicated vaginal deliveries (informed consent was given from all participants, and the projectwas approved by the local ethical committee). Venous blood and CSF were collected from patients with no neurological or metabolic disturbances, who were given lumbar anaesthesia before undergoing urological surgery.
Calculations.
Yellow Springs Instruments gives the following equation for converting whole blood lactate to equivalent plasma lactate values:
where c is the molar concentration, Ht is the hematocrit of the whole-blood sample, PvB is venous plasma, and vB is venous whole blood. We tested this equation and found it to be highly inadequate. However, from our experimental data we propose another equation to handle these calculations:
Statistical methods. The statistical calculations (mean, standard deviation, regression analysis, and paired t-test) were performed by use of a statistical program package (Statgraphics; STSC Inc.) in a PC Olivetti M24 SP. Table 1 shows the precision of lactate measurements in plasma and whole blood at different lactate concentrations. Table 2 shows the effect of storage at three temperature ranges-0-4 #{176}C, 22-24 #{176}C, and 37-38 #{176}C-with heparin or potassium fluoride as anticoagulant and as reagent for controlling lactate metabolism in whole blood. Figure 1 shows the effect of the hematocrit on converting measurements in whole blood compared with corresponding values of plasma. The plot of the plasma lactate concentration divided by the concentration in whole blood (PvB)/c. (vB)) vs 1/(1 -0.88#{149}Ht) gives a highly significant correlation (r = 0.989, P <10-s). Table 3 shows paired reference values for lactate in capillary and venous whole blood. By the paired t-test, the difference between capillary whole blood and venous whole blood was highly significant; the mean difference was 0.2 mmol/L (t = 4.17).
Results
Paired values for maternal venous cord artery and cord vein whole blood are also given for 24 uncomplicated vaginal deliveries. A weak statistical difference was found between lactate in whole blood from cord artery and cord vein (paired t-test): mean difference, 0.28 mmol/L (t = 2.29, P <0.031). previously published amperometric measurements with the LA 640 (3). We concluded from aqueous standards that care patients; therefore, the dilution factor may cause analytical errors. The extracellular concentration displayed on the instrument is the plasma lactate concentration if the packed cell volume is zero. The higher the A significant difference in lactate was found between hematocrit, the greater the difference between the disvenous cord blood and maternal venous blood (paired t played lactate concentration and the true lactate concentest): mean difference, 0.69 minol/L (t = -2.85, P <0.009).
tration (Figure 1 posed another algorithm (equation 2). Although we think There was only a weak correlation between lactate in our whole-blood/plasma correction algorithm (for hematomaternal venous blood and cord arterial blood (r = 0.373, crit between 0.06 and 0.82) is better than the one proposed P <0.07).
by YSI, the hematocrit effect on diluting the sample into a Paired values for lactate are given for venous blood and specific reaction chamber volume still seems to give an CSF. A significant difference was found between venous erroneous bias in estimated results of about -0.54 to 0.73 lactate and lactate in CSF (paired t-test): mean difference, mmoIJL (2.5 and 97.5 percentiles for differences between 0.78 mmol/L (t = -9.47).
directly measured plasma lactate and the value estimated By correctingvalues for whole blood to values for plasma, by use of equation 2). the significant difference disappeared (P >0. which was highly significant (P <0.0001). We have not been able to find results compatible with this difference in the literature. Our results for maternal blood and cord blood at delivery seem consistent with previously published values (5) . The significant difference (0.28 mmol/L, P <0.031) between cord arterial blood and cord vein blood lactate appears reasonable from a metabolic point of view.
The highly significant difference (0.69 mmol/L, P <0.009) between maternal venous blood and cord venous blood may indicate some placental production of this metabolite. Our upper 99.7% (mean + 3s = 2.5 mmol/L) limit for CSF from normal adults seems compatible with a previously published pathological cutoff value for adults with diseases of the central nervous system (11).
Although amperometric measurements of lactate in whole blood seem to provide prompt guidance and highly acceptable laboratory support for obstetric and cardiorespiratory patients in intensive care, the instrumental design of the present lactate stat analyzer (YSI) does not completely meet our demands for an optimal stat instrument. Future developments in this area may, however, produce second-generation instruments that satisfy the stat application characteristics of easy, quick, and around-the-clock intensive laboratory service for this interesting metabolite.
